Perfromance Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Perfromance Wealth Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-31,675	Closed	-$1.84M	–	166
2023 Q3	$1.84M	Buy	31,675 +8,954	+39%	+$549K	0.09%	63
2023 Q2	$1.47M	Buy	22,721 +5,200	+30%	+$349K	0.07%	67
2023 Q1	$1.21M	Buy	17,521 +9,746	+125%	+$687K	0.06%	70
2022 Q4	$559K	Buy	7,775 +1,467	+23%	+$111K	0.03%	96
2022 Q3	$448K	Sell	6,308 -19	-0.3%	-$1.38K	0.03%	104
2022 Q2	$487K	Sell	6,327 -75	-1%	-$5.71K	0.03%	99
2022 Q1	$468K	Sell	6,402 -697	-10%	-$46.8K	0.02%	111
2021 Q4	$443K	Buy	+7,099	New	+$416K	0.02%	121

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Perfromance Wealth Partners's BMY Position: Q4 2023 in Review

Perfromance Wealth Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 31,675 shares — an estimated $1.84M sold.

Perfromance Wealth Partners first reported a position in BMY in Q4 2021 and held it in 8 quarters. The position peaked at $1.84M in Q3 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Perfromance Wealth Partners reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Perfromance Wealth Partners sold 31,675 Bristol-Myers Squibb shares in Q4 2023, an estimated $1.84M.
Perfromance Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 8 quarters.
Perfromance Wealth Partners's Bristol-Myers Squibb position peaked at $1.84M in Q3 2023.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Perfromance Wealth Partners's 13F filing for Q4 2023, filed 22 Jan 2024.